Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection

Journal of Virology

Volumn 79, Issue 10, 2005, Pages 6441-6448

  Schmitz, Nicole ^a   Kurrer, Michael ^b   Bachmann, Martin F ^c   Kopf, Manfred ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c CYTOS BIOTECHNOLOGY AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CELL KILLING; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE INDUCTION; IMMUNE RESPONSE; INFLAMMATION; INFLUENZA VIRUS; LUNG DISEASE; LYMPHOCYTE MIGRATION; LYMPHOID ORGAN; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SURVIVAL; T LYMPHOCYTE ACTIVATION; VIRUS LOAD;

INFLUENZA VIRUS;

EID: 18144380291     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.10.6441-6448.2005     Document Type: Article

References (47)

1. Alcami, A., and G. L. Smith. 1992. A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 71:153-167.
2. Bachmann, M. F., B. Ecabert, and M. Kopf. 1999. Influenza virus: a novel method to assess viral and neutralizing antibody titers in vitro. J. Immunol. Methods 225:105-111.
3. Baumgarth, N., O. C. Herman, G. C. Jager, L. Brown, and L. A. Herzenberg. 1999. Innate and acquired humoral immunities to influenza viras are mediated by distinct arms of the immune system. Proc. Natl. Acad. Sci. USA 96:2250-2255.
4. Baumgarth, N., O. C. Herman, G. C. Jager, L. E. Brown, L. A. Herzenberg, and J. Chen. 2000. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J. Exp. Med. 192:271-280.
5. Bowie, A., E. Kiss-Toth, J. A. Symons, G. L. Smith, S. K. Dower, and L. A. O'Neill. 2000. A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc. Natl. Acad. Sci. USA 97:10162-10167.
6. Calkins, C. M., D. D. Bensard, B. D. Shames, E. J. Pulido, E. Abraham, N. Fernandez, X. Meng, C. A. Dinarello, and R. C. McIntyre, Jr. 2002. IL-1 regulates in vivo C-X-C chemokine induction and neutrophil sequestration following endotoxemia. J. Endotoxin Res. 8:59-67.
7. Chu, W. M., D. Ostertag, Z. W. Li, L Chang, Y. Chen, Y. Hu, B. Williams, J. Perrault, and M. Karin. 1999. JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity 11:721-731.
8. Conlan, J. W., and R. J. North. 1994. Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody. J. Exp. Med. 179:259-268.
9. Conn, C. A., J. L. McClellan, H. F. Maassab, C. W. Smitka, J. A. Majde, and M. J. Kluger. 1995. Cytokines and the acute phase response to influenza virus in mice. Am. J. Physiol. 268:R78-R84.
10. Dinarello, C. A. 1992. Role of interleukin-1 in infectious diseases. Immunol. Rev. 127:119-146.
11. Doherty, P. C., W. Allan, M. Eichelberger, and S. R. Carding. 1992. Roles of alpha beta and gamma delta T cell subsets in viral immunity. Annu. Rev. Immunol. 10:123-151.
12. Eichelberger, M., W. Allan, M. Zijlstra, R. Jaenisch, and P. C. Doherty. 1991. Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells. J. Exp. Med. 174:875-880.
13. Eriksson, U., M. O. Kurrer, I. Sonderegger, G. Iezzi, A. Tafuri, L. Hunziker, S. Suzuki, K. Bachmaier, R. M. Bingisser, J. M. Penninger, and M. Kopf. 2003. Activation of dendritic cells through the interleukin 1 receptor 1 is critical for the induction of autoimmune myocarditis. J. Exp. Med. 197:323-331.
14. Reference deleted.
15. Glaccum, M. B., K. L. Stocking, K. Charrier, J. L. Smith, C. R. Willis, C. Maliszewski, D. J. Livingston, J. J. Peschon, and P. J. Morrissey. 1997. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. J. Immunol. 159:3364-3371.
16. Graham, M. B., and T. J. Braciale. 1997. Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice. J. Exp. Med. 186:2063-2068.
17. Haq, M., J. Norman, S. R. Saba, G. Ramirez, and H. Rabb. 1998. Role of IL-1 in renal ischemic reperfusion injury. J. Am. Soc. Nephrol. 9:614-619.
18. Horai, R., S. Saijo, H. Tanioka, S. Nakae, K. Sudo, A. Okahara, T. Ikuse, M. Asano, and Y. Iwakura. 2000. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J. Exp. Med. 191:313-320.
19. Hurme, M., and M. Helminen. 1998. Polymorphism of the IL-1 gene complex in Epstein-Barr virus seronegative and seropositive adult blood donors. Scand. J. Immunol. 48:219-222.
20. Hurme, M., and M. Helminen. 1998. Resistance to human cytomegalovirus infection may be influenced by genetic polymorphisms of the tumour necrosis factor-alpha and interleukin-1 receptor antagonist genes. Scand. J. Infect. Dis. 30:447-449.
21. Hussell, T., A. Pennycook, and P. J. Openshaw. 2001. Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology. Eur. J. Immunol. 31:2566-2573.
22. Jabs, W. J., H. J. Wagner, P. Schlenke, and H. Kirchner. 2000. The primary and memory immune response to Epstein-Barr virus infection in vitro is characterized by a divergent production of IL-1beta/IL-6 and IL-10. Scand. J. Immunol. 52:304-308.
23. Jacobs, B. L., and J. O. Langland. 1996. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 219:339-349.
24. Janeway, C., Jr., and R. Medzhitov. 2000. Viral interference with IL-1 and toll signaling. Proc. Natl. Acad. Sci. USA 97:10682-10683.
25. Juffermans, N. P., S. Florquin, L. Camoglio, A. Verbon, A. H. Kolk, P. Speelman, S. J. van Deventer, and T. van Der Poll. 2000. Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis. J. Infect. Dis. 182:902-908.
26. Kato, A., C. Gabay, T. Okaya, and A. B. Lentsch. 2002. Specific role of interleukin-1 in hepatic neutrophil recruitment after ischemia/reperfusion. Am. J. Pathol. 161:1797-1803.
27. Koh, Y., B. M. Hybertson, E. K. Jepson, O. J. Cho, and J. E. Repine. 1995. Cytokine-induced neutrophil chemoattractant is necessary for interleukin-1-induced lung leak in rats. J. Appl. Physiol. 79:472-478.
28. Kopf, M., F. Brombacher, and M. F. Bachmann. 2002. Role of IgM antibodies versus B cells in influenza virus-specific immunity. Eur. J. Immunol. 32:2229-2236.
29. Kozak, W., H. Zheng, C. A. Conn, D. Soszynski, L. H. van der Ploeg, and M. J. Kluger. 1995. Thermal and behavioral effects of lipopolysaccharide and influenza in interleukin-1 beta-deficient mice. Am. J. Physiol. 269:R969-R977.
30. Labow, M., D. Shuster, M. Zetterstrom, P. Nunes, R. Terry, E. B. Cullinan, T. Bartfai, C. Solorzano, L. L. Moldawer, R. Chizzonite, and K. W. McIntyre. 1997. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. J. Immunol. 159:2452-2461.
31. Maggi, L. B., Jr., J. M. Moran, R. M. Buller, and J. A. Corbett 2003. ERK activation is required for double-stranded RNA- and virus-induced interleukin-1 expression by macrophages. J. Biol. Chem. 278:16683-16689.
32. Nakae, S., M. Asano, R. Horai, N. Sakaguchi, and Y. Iwakura. 2001. IL-1 enhances T cell-dependent antibody production through induction of CD40 ligand and OX40 on T cells. J. Immunol. 167:90-97.
33. Nakae, S., Y. Komiyama, H. Yokoyama, A. Nambu, M. Umeda, M. Iwase, I. Homma, K. Sudo, R. Horai, M. Asano, and Y. Iwakura. 2003. IL-1 is required for allergen-specific Th2 cell activation and the development of airway hypersensitivity response. Int. Immunol. 15:483-490.
34. Nicklin, M. J., D. E. Hughes, J. L. Barton, J. M. Ure, and G. W. Duff. 2000. Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J. Exp. Med. 191:303-312.
35. Ray, C. A., R. A. Black, S. R. Kronheim, T. A. Greenslreet, P. R. Sleath, G. S. Salvesen, and D. J. Pickup. 1992. Viral inhibition of inflammation: cowpox viras encodes an inhibitor of the interleukin-1 beta converting enzyme. Cell 69:597-604.
36. Riberdy, J. M., K. J. Flynn, J. Stech, R. G. Webster, J. D. Altman, and P. C. Doherty. 1999. Protection against a lethal avian influenza A virus in a mammalian system. J. Virol. 73:1453-1459.
37. Rogers, H. W., K. C. Sheehan, L. M. Brunt, S. K. Dower, E. R. Unanue, and R. D. Schreiber. 1992. Interleukin 1 participates in the development of anti-Listeria responses in normal and SCID mice. Proc. Natl. Acad. Sci. USA 89:1011-1015.
38. Rogers, H. W., and E. R. Unanue. 1993. Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice. Infect. Immun. 61:5090-5096.
39. Sangster, M. Y., J. M. Riberdy, M. Gonzalez, D. J. Topham, N. Baumgarth, and P. C. Doherty. 2003. An early CD4+ T cell-dependent immunoglobulin A response to influenza infection in the absence of key cognate T-B interactions. J. Exp. Med. 198:1011-1021.
40. Schmitz, N., M. Kurrer, and M. Kopf. 2003. The IL-1 receptor 1 is critical for Th2 cell type airway immune responses in a mild but not in a more severe asthma model. Eur. J. Immunol. 33:991-1000.
41. Shanley, T. P., H. Schmal, R. L. Warner, E. Schmid, H. P. Friedl, and P. A. Ward. 1997. Requirement for C-X-C chemokines (macrophage inflammatory protein-2 and cytokine-induced neutrophil chemoattractant) in IgG immune complex-induced lung injury. J. Immunol. 158:3439-3448.
42. Spriggs, M. K., D. E. Hruby, C. R. Maliszewski, D. J. Pickup, J. E. Sims, R. M. Buller, and J. VanSlyke. 1992. Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell 71:145-152.
43. Swiergiel, A. H., G. N. Smagin, L. J. Johnson, and A. J. Dunn. 1997. The role of cytokines in the behavioral responses to endotoxin and influenza virus infection in mice: effects of acute and chronic administration of the interleukin-1-receptor antagonist (IL-1ra). Brain Res. 776:96-104.
44. Witkin, S. S., I. M. Linhares, S. Gerber, M. E. Caetano, and A. C. Segurado. 2001. Interleukin-1 receptor antagonist gene polymorphism and circulating levels of human immunodeficiency virus type 1 RNA in Brazilian women. J. Virol. 75:6242-6244.
45. Wong, J. P., E. G. Saravolac, J. G. Clement, and L. P. Nagata. 1997. Development of a murine hypothermia model for study of respiratory tract influenza virus infection. Lab. Anim. Sci. 47:143-147.
46. Reference deleted.
47. Zhu, H., and C. Liu. 2003. Interleukin-1 inhibits hepatitis C virus subgenomic RNA replication by activation of extracellular regulated kinase pathway. J. Virol. 77:5493-5498.